|
ZNF776 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.33060000479568E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.38790000182266E-08 |
| Normal-vs-Stage2 |
3.259200E-03 |
| Normal-vs-Stage3 |
1.192490E-04 |
| Normal-vs-Stage4 |
3.53880000000251E-05 |
| Stage1-vs-Stage2 |
9.571600E-01 |
| Stage1-vs-Stage3 |
5.346200E-01 |
| Stage1-vs-Stage4 |
4.198600E-01 |
| Stage2-vs-Stage3 |
6.846000E-01 |
| Stage2-vs-Stage4 |
4.860000E-01 |
| Stage3-vs-Stage4 |
7.054000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.30810000054105E-07 |
| Normal-vs-AfricanAmerican |
2.30829999999793E-05 |
| Normal-vs-Asian |
8.17790000000596E-05 |
| Caucasian-vs-AfricanAmerican |
9.342600E-01 |
| Caucasian-vs-Asian |
3.792800E-01 |
| AfricanAmerican-vs-Asian |
3.200000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.94859994595964E-09 |
| Normal-vs-Female |
8.635800E-03 |
| Male-vs-Female |
5.380300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.37759999999199E-05 |
| Normal-vs-Extreme_Weight |
6.39889996545406E-09 |
| Normal-vs-Obese |
1.197550E-03 |
| Normal-vs-Extreme_Obese |
6.15099999999869E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.349000E-01 |
| Normal_Weight-vs-Obese |
2.145000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.010600E-01 |
| Extreme_Weight-vs-Obese |
2.293500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.203800E-01 |
| Obese-vs-Extreme_Obese |
1.656980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.918300E-03 |
| Normal-vs-Age(41-60Yrs) |
6.199600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.85320003787126E-09 |
| Normal-vs-Age(81-100Yrs) |
9.41960000000464E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.903800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.554000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.839760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.756000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.418040E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.143800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.54810000047223E-07 |
| Normal-VS-Type2 PRCC |
2.23180363079223E-11 |
| Normal-VS-KIRP CIMP |
4.288100E-02 |
| Normal-VS-Unclassified PRCC |
7.448200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.882500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.438000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.437600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.122200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.523300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.017600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89799953531633E-10 |
| Normal-vs-N1 |
4.743800E-03 |
| Normal-vs-N2 |
9.75389999999798E-05 |
| N0-vs-N1 |
1.997960E-01 |
| N0-vs-N2 |
3.383400E-01 |
| N1-vs-N2 |
2.504600E-01 |
|
|
